tiprankstipranks
BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF

BioVaxys Technology (BVAXF) Balance Sheet

29 Followers

BioVaxys Technology Balance Sheet

BioVaxys Technology's total assets for Q3 2023 were C$1.41M, a decrease of -46.75% from the previous quarter. BVAXF total liabilities were C$2.04M for the fiscal quarter, a 16.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Oct 22Oct 21Oct 20Oct 19Oct 18
Total Assets
C$ 865.56KC$ 8.50MC$ 10.46MC$ 306.26KC$ 108.74K
Total Liabilities
C$ 1.64MC$ 326.86KC$ 900.09KC$ 116.15KC$ 184.66K
Total Equity Gross Minority
C$ -773.53KC$ 8.18MC$ 9.56MC$ 190.11KC$ -75.92K
Total Capitalization
C$ -773.53KC$ 8.18MC$ 9.56MC$ 190.11KC$ -75.92K
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in CAD

BioVaxys Technology Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis